About Prenetics
Prenetics is a publicly listed company based in Hong Kong (China) founded in 2009 by Michael M Yang and Danny Yeung. Health risks are identified through online genetic and diagnostic testing. Prenetics has raised $67.65 million across 6 funding rounds from investors including David Beckham, Apis Partners and Alibaba Entrepreneurs Fund. The company has 285 employees. Prenetics has completed 6 acquisitions, including ACT Genomics, DNAFit and Europa Sports Products. Its chief executive, as recorded, is Danny Yeung. Its website prenetics.com draws about 52 thousand monthly visits. Prenetics offers products and services including CircleDNA, Insighta, ACT Genomics, and IM8. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity in India is Prenetics Innovation Labs Private Limited (U73100TN2019PTC128283).
Company details
Prenetics was founded in 2009 in Hong Kong, China, within the health technology sector. An online platform is operated for genetic and diagnostic testing to identify health risks. Covid-19 PCR tests and rapid test kits have been developed, with samples analyzed via whole-genome sequencing. A DNA screening test for colon cancer detection has also been created, supporting diagnostic services in the region.
- Headquarters Hong Kong, China
- Employees 285
- Founders Michael M Yang, Danny Yeung
- Stage Public
- SectorsHealthcare
- Website prenetics.com
- Social LinkedIn X Facebook Instagram
- Legal Name Prenetics Global Limited
- Indian entity revenue₹39,955
FY 2025 · -100% YoY
- Indian entity net loss-₹28.9 Lakh
FY 2025 · -7221% margin
- Indian entity EBITDA-₹28.8 Lakh
FY 2025 · -7202% margin
- Total Equity Funding$67.65M (USD)
in 6 rounds
- Latest Funding Round$48M (USD), Post-IPO
Oct 2025
- InvestorsApis Partners
& 19 more
- Employee Count285
- Investments & AcquisitionsACT Genomics
& 5 more
Associated legal entities of Prenetics
Prenetics operates through Prenetics Innovation Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Prenetics Innovation Labs Private Limited CIN U73100TN2019PTC128283 | Active | 26 Mar 2019 | Chennai, Tamil Nadu | ₹0.0 Cr | 21 | 2 | View details |
Products & Services of Prenetics
Prenetics offers a comprehensive portfolio of products and services, including CircleDNA, Insighta, ACT Genomics, and IM8.
Offers personalized DNA tests for health management and prevention.
Provides multi-cancer screening technologies for early diagnosis.
Delivers genomic profiling for solid tumor treatments.
Focuses on health supplements and wellness products for consumers.
Funding Insights of Prenetics
Prenetics has successfully raised a total of $67.65M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $48 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $67.65M
- Total Rounds 6
- Last Round Post-IPO — $48M
- First Round $2.65M
(Dec 2014)
- Investors Count 20
All 6 funding rounds of Prenetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $48M | Post-IPO | – | – | |
| Jul 2024 | Post-IPO | – | – | ||
| Sep 2020 | $15M | Series B | – | Apis Partners | |
| Oct 2017 | $40M | Series B | – | Beyond Ventures, Alibaba Entrepreneurs Fund | |
| Mar 2016 | $10M | Series A | – | Ping An Ventures | |
| Dec 2014 | $2.65M | Seed | – | – |
20 investors in total: 19 institutional and 1 angel.
Investors in Prenetics
Prenetics has secured backing from 20 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include David Beckham, Apis Partners and Alibaba Entrepreneurs Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital asset management firm | apis.pe | London, United Kingdom | ||
Capital and guidance are provided to startups for growth. | ent-fund.org | Hong Kong, China | ||
Venture capital funding is provided by Beyond Ventures for startups. | beyondventures.hk | Hong Kong, Hong Kong | ||
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors | pinganventures.com | Pudong, China | ||
Early-stage tech-focused venture capital firm investing primarily in Southeast Asia | venturra.com | Jakarta, Indonesia | ||
Venture capital is provided by Reapra in multiple sectors. | reapra.com | Singapore, Singapore | ||
| mfund.com | ||||
VC and PE investments are managed stage-agnostically across multiple sectors. | cuiasia.com | Wan Chai, China | ||
Seed-stage investments are targeted globally by this venture capital firm. | durians.500.co | Singapore, Singapore |
Investor details for Prenetics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Prenetics Innovation Labs Private Limited (Prenetics)
Prenetics Innovation Labs Private Limited is the primary company behind Prenetics. The board of Prenetics Innovation Labs Private Limited currently have 2 directors; the longest-serving is Krishnaiah Shankarnarayana, appointed in 2019. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Krishnaiah Shankarnarayana DIN 08400705 | Director | 26 Mar 2019 | 7 yrs 7 mo | Prenetics Innovation Labs Private Limited |
| Senthil Kumar DIN 11306323 | Director | 18 Sep 2025 | 1 yr 1 mo | Prenetics Innovation Labs Private Limited |
People of Prenetics
39 people are tracked at Prenetics (14 in leadership, 15 in board & advisors, 10 in team); the tracked headcount is 285.
| Name | Role | Group |
|---|---|---|
Michael M Yang | Co-Founder | Leadership |
Danny Yeung | Co-Founder & CEO | Leadership |
Joel Neoh | Chief Consumer Officer | Leadership |
Samantha Kwok | Chief of Staff to Group CEO & VP, People & Operations | Leadership |
Senthil Sundaram | Chief Clinical Officer | Leadership |
Belinda Cheung | VP, Research & Development | Leadership |
Lawrence Tzang | Chief Scientific Officer & Co-founder | Leadership |
Andrew Steele | Chief Product Officer, EMEA | Leadership |
Stephen Lo | Chief Financial Officer | Leadership |
Alan Thomas | VP, Supply Chain & Operations | Leadership |
Ajay Singh Gusain | Head Of Technology Operations | Leadership |
Samson Ng | Vice President - Finance | Leadership |
Cheung Arthur Kwok Leung | Laboratory Director (ngs) | Leadership |
Angela Cheung | Head Of Corporate Finance | Leadership |
Ben Cheng | Director | Board & advisors |
Pasi A. Jänne | Advisor | Board & advisors |
Hua-Chien Chen | Advisor | Board & advisors |
Tony S. K. Mok | Advisor | Board & advisors |
Pan-chyr Yang | Advisor | Board & advisors |
James Dinicolantonio | Advisor | Board & advisors |
19 more people are available in the full profile.
Complete people profiles for Prenetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Prenetics
Prenetics is a publicly listed company on the NASDAQ with ticker symbol PRE in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Sep 2021
- Listed onNASDAQ: PRE
- Listed entityPrenetics Global Limited
- Exchange sectorFinance
- ISINKYG722451229
- Share price$21.27 (+0.52% on the day) · 2026-10-13
- Market capitalisation$364.6M
- EPS (diluted, trailing year)$-4.17
- Volume (last session)96,524
Financials of Prenetics
Figures of Prenetics Innovation Labs Private Limited, the primary company behind Prenetics, for FY 2025. Revenue was ₹39,955 (-100% year on year). Net loss was -₹28.9 Lakh (-7221% margin). EBITDA was -₹28.8 Lakh (-7202% margin). Revenue has grown at a compounded annual rate of -92% over three years and -69% over five years.
- ₹39,955Revenue · FY 2025 · -100% YoY
- -₹28.9 LakhNet loss · -7221% margin
- -₹28.8 LakhEBITDA · -7202% margin
- ₹5 LakhPaid-up capital
- 21Employees (provident fund records)
- -92%Revenue CAGR, 3 years
- -69%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $92.4M | -$37.7M | -$35.9M |
| 2024 | $15.9M | -$46.3M | -$35.8M |
| 2023 | $21.7M | -$62.7M | -$44.7M |
| 2022 | $13.2M | -$190.4M | -$58.9M |
| 2021 | $275.9M | -$174.0M | -$3.0M |
Balance sheet, profit and loss, cash flow and ratios of Prenetics Innovation Labs Private Limited are on its company page.
Detailed financial statements for Prenetics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prenetics
Prenetics has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ACT Genomics, DNAFit and Europa Sports Products.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
End-to-end fulfillment solutions are provided to ecommerce brands by Hubmatrix. | hubmatrix.com | Charlotte, United States | 2020 | Aug 2024 | •••• | |
Health supplements are distributed wholesale to gyms and stores. | europasports.com | Charlotte, United States | 1990 | Aug 2024 | •••• | |
Genomics services for cancer clinical and research needs are delivered. | actgenomics.com | Taipei, Taiwan | 2014 | Dec 2022 | $39.9M | |
Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology. | oxsed.com | United Kingdom | 2020 | Oct 2020 | •••• | |
Mental fitness and sleep tracking app is provided by Kelaa. | kelaa.me | London, United Kingdom | 2013 | Jan 2019 | •••• | |
Personalized fitness and diet recommendations are derived from genetic analysis. | dnafit.com | London, United Kingdom | 2013 | Apr 2018 | $10M |
Complete acquisition details for Prenetics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Prenetics
10 dated milestones of Prenetics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Prenetics is founded.
- Funding First funding round of $2.6M.
- Acquisition Acquires DNAFit.
- Acquisition Acquires Kelaa.
- Acquisition Acquires Oxsed.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ACT Genomics.
- Acquisition Acquires Hubmatrix.
- Acquisition Acquires Europa Sports Products.
- Funding Latest funding round, Post-IPO, of $48.0M.
Web traffic of Prenetics
The website of Prenetics (prenetics.com) receives about 52.2K visits a month.
- Monthly visits52.2K
▲ 19.6% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prenetics
Complete news archive for Prenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prenetics
Prenetics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Prenetics is headquartered in Hong Kong, China.
Danny Yeung is the CEO of Prenetics, as recorded in our data. They have also founded this company.
Prenetics is a funded company, having raised a total of $67.65M across 6 funding rounds to date. The company's 1st funding round was a Seed of $2.65M, raised on Dec 2014.
Prenetics has 285 employees.
The primary company behind Prenetics, Prenetics Innovation Labs Private Limited, reported revenue of ₹39,955 for FY 2025, down 100% year on year.
Prenetics was founded in 2009 in Hong Kong, China, within the health technology sector. An online platform is operated for genetic and diagnostic testing to identify health risks. Covid-19 PCR tests and rapid test kits have been developed, with samples analyzed via whole-genome sequencing. A DNA screening test for colon cancer detection has also been created, supporting diagnostic services in the region.
Prenetics offers CircleDNA, Insighta, ACT Genomics, and IM8.
Yes, Prenetics is publicly traded on NASDAQ under the ticker symbol PRE.
Prenetics has made 6 acquisitions, including ACT Genomics, DNAFit, and Europa Sports Products.
Prenetics has 20 investors. Key investors include David Beckham, Apis Partners, Alibaba Entrepreneurs Fund, Beyond Ventures, and Ping An Ventures.
Prenetics operates through Prenetics Innovation Labs Private Limited.